Literature DB >> 19830398

[Prasugrel or clopidogrel in patients with coronary intervention].

K Schrör1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19830398     DOI: 10.1007/s00108-009-2519-3

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  4 in total

1.  Prasugrel versus clopidogrel in patients with acute coronary syndromes.

Authors:  Stephen D Wiviott; Eugene Braunwald; Carolyn H McCabe; Gilles Montalescot; Witold Ruzyllo; Shmuel Gottlieb; Franz-Joseph Neumann; Diego Ardissino; Stefano De Servi; Sabina A Murphy; Jeffrey Riesmeyer; Govinda Weerakkody; C Michael Gibson; Elliott M Antman
Journal:  N Engl J Med       Date:  2007-11-04       Impact factor: 91.245

2.  Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study.

Authors:  Jean-Philippe Collet; Jean-Sébastien Hulot; Anna Pena; Eric Villard; Jean-Baptiste Esteve; Johanne Silvain; Laurent Payot; Delphine Brugier; Guillaume Cayla; Farzin Beygui; Gilbert Bensimon; Christian Funck-Brentano; Gilles Montalescot
Journal:  Lancet       Date:  2008-12-26       Impact factor: 79.321

3.  Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial.

Authors:  Alan D Michelson; Andrew L Frelinger; Eugene Braunwald; William E Downey; Dominick J Angiolillo; Nicholas P Xenopoulos; Joseph A Jakubowski; Youfu Li; Sabina A Murphy; Jie Qin; Carolyn H McCabe; Elliott M Antman; Stephen D Wiviott
Journal:  Eur Heart J       Date:  2009-05-12       Impact factor: 29.983

4.  Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes.

Authors:  Jessica L Mega; Sandra L Close; Stephen D Wiviott; Lei Shen; Richard D Hockett; John T Brandt; Joseph R Walker; Elliott M Antman; William L Macias; Eugene Braunwald; Marc S Sabatine
Journal:  Circulation       Date:  2009-05-04       Impact factor: 29.690

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.